Régions: North Slave Region
étiquettes: health, infants, pandemic, hospitalization, respiratory infection
| chercheur principal: | Goldfarb, David (3) |
| Nᵒ de permis: | 16813 |
| Organisation: | University of British Columbia (UBC) |
| Année(s) de permis: |
2021
|
| Délivré: | avr. 27, 2021 |
| Équipe de projet: | Michelle Dittrick, Mai-Lei (Maggie) Kinshella, Darcy Scott, |
Objectif(s): To determine the rate and outcome of infant respiratory infection hospitalizations; to assess the effectiveness of the palivizumab vaccination program in preventing hospital admissions due (respiratory syncytial virus) RSV infections in Nunavut; understand the factors associated with severe hospital stays due to respiratory tract infections; and assess the potential indirect impact of the COVID-19 pandemic measures on burden of infant admissions to hospital for respiratory infections.
Description du projet: This licence has been issued for the scientific research application No.4873. The research team propose to identify the respiratory infection admissions at all hospitals serving Nunavummiut children under one year of age from 2010-2020. The objectives of the study are to 1) determine the rate and outcome of infant respiratory infection hospitalizations; 2) assess the effectiveness of the palivizumab vaccination program in preventing hospital admissions due RSV infections in Nunavut; 3) understand the factors associated with severe hospital stays due to respiratory tract infections; and, 4) assess the potential indirect impact of the COVID-19 pandemic measures on burden of infant admissions to hospital for respiratory infections. The research team will review hospital charts at the six hospitals serving the population of Nunavut: Qikiqtani General Hospital (QGH), Stanton Territorial Hospital (STH), Montreal Chil... Plus de résultats
